Evaluation of the cause-effect relationship of plasma cyclic glycine proline and the manifestations of type 2 diabetes mellitus (T2DM) and its associated vascular complications

The cGP LAB, New Zealand0 个研究点目标入组 77 人开始时间: 2024年7月31日最近更新: 2024年8月12日

适应症

试验速览

暂无简介。

•1. Male and female participants, 45 to 80 years of age
•2. Medical history and clinical diagnosis of T2DM either without or with medical history and clinical diagnosis of dyslipidaemia, hypertension and/or clinical diagnosis of foot DP

•1. Type 1 diabetes
•2. Pregnancy related T2DM and/or hypertension
•3. Poorly controlled glucose metabolism (fasting glucose >15 mmol/L)
•4. T2DM with severe complications such as diabetes ketoacidosis, stage 4 diabetic nephropathy and diabetic foot ulcer
•5. Other causes of hypertension and chronic kidney diseases
•6. Drug, injury or neurological condition induced peripheral neuropathy
•7. Medical history of degenerative conditions
•8. Cognitive impairment and major mental health issues
•9. Severe depression and anxiety

发起方

The cGP LAB, New Zealand